Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study will look at how effective the study drug(Savolitinib combined with Osimertinib) versus Pemetrexed combined with platinum in treatment of patients with locally advanced or metastatic NSCLC with MET amplification after failure of the first-line EGFR inhibitor therapy.
Epistemonikos ID: 55dd8960dfd790976ff74fee5ac0d73b2702075b
First added on: May 09, 2024